Michael S. Wolff - Concepedia

Author

Michael S. Wolff

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

M.S. Wolff, Michael S. Wolff

Publications

290

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Michael S. Wolff is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	252
2	Biochemistry	7	7	252
3	Natural Sciences	5	5	224
4	Chemical Biology	2	2	53
5	Immunology	1	1	36

Michael S. Wolff

Publications

290

Citations

H-Index

Page 1

	Year	Citations
Discovery of Novel Tricyclic Full Agonists for the G-Protein-Coupled Niacin Receptor 109A with Minimized Flushing in Rats Hong C. Shen, Fa‐Xiang Ding, Qiaolin Deng, Journal of Medicinal Chemistry Tricyclic AnaloguesMedicinal ChemistryBiochemistryFunctional SelectivityMedicine	2009	78
Discovery of a Biaryl Cyclohexene Carboxylic Acid (MK-6892): A Potent and Selective High Affinity Niacin Receptor Full Agonist with Reduced Flushing Profiles in Animals as a Preclinical Candidate Hong C. Shen, Fa‐Xiang Ding, Subharekha Raghavan, Journal of Medicinal Chemistry Potent Niacin ReceptorExcellent Receptor ActivityPharmacotherapyExperimental PharmacologyMedicinal Chemistry	2010	57
Development of the rat sublingual gland: A light and electron microscopic immunocytochemical study Michael S. Wolff, Lily Mirels, J. Lagner, The Anatomical Record	2001	38
Discovery of Biaryl Anthranilides as Full Agonists for the High Affinity Niacin Receptor Hong C. Shen, Fa‐Xiang Ding, Silvi Luell, Journal of Medicinal Chemistry Drug TargetImmunologyPharmacotherapyMedicinal ChemistryReceptor Gpr109a	2007	36
Tetrahydro anthranilic acid as a surrogate for anthranilic acid: Application to the discovery of potent niacin receptor agonists Subharekha Raghavan, Giancarlo Tria, Hong C. Shen, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryTetrahydro Anthranilic AcidBioorganic ChemistryDrug TargetBiochemistry	2008	28
Discovery of imidazole carboxamides as potent and selective CCK1R agonists Cheng Zhu, Alexa R. Hansen, Thomas J. Bateman, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryDrug TargetBiochemistryFunctional Selectivity	2008	25
The discovery of high affinity agonists of GPR109a with reduced serum shift and improved ADME properties Jason E. Imbriglio, Daniel A. DiRocco, Rena Bodner, Bioorganic & Medicinal Chemistry Letters Signal TransductionBiochemistryReduced Serum ShiftMedicineG Protein-coupled Receptor	2010	15
GPR109a agonists. Part 2: Pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a Jason E. Imbriglio, Sookhee Chang, Rui Liang, Bioorganic & Medicinal Chemistry Letters Molecular PhysiologyHuman Orphan G-proteinBiochemistryReceptor Gpr109aMedicine	2010	13

Page 1